Those at the ASX who are responsible for determining the SP sensitivity are as clueless as the market itself when it comes to biotech news. But maybe they know actually know that. I'm not complaining... better to be invested in a stock that you know is being underestimated, is undervalued and underrated!
What a company this is!!! Professor Donald M. O'Rourke "... has been recognized annually in Philadelphia Magazine’s list of Top Doctors since 2005, and has also been named one of the Best Doctors in America and one of America’s Top Doctors annually since in 2006."
My goodness, Steve's mission statement about PTX being "Licensed by the best and working with best" keeps ringing true!
